Managers / Q4 2025 · view latest →
AMAZON COM INC
CIK 0001018724 · 410 TERRY AVENUE NORTH, SEATTLE, WA, 98109 · 2062661000
Summary
Amazon Com Inc reported $3.5B in U.S.-listed holdings across 6 positions for Q4 2025.
The portfolio is heavily concentrated: RIVN alone accounts for 88.6% of reported value.
Compared with Q3 2025, the fund opened 2 new positions and exited 3.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 100.0% · $3.5B
Quarter-over-Quarter Changes full breakdown →
vs Q3 2025 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| BETABETA TECHNOLOGIES INC | NEW | +11.75M | 11.75M | +$332M | $332M |
| IONQIONQ INC | NEW | +6.7K | 6.7K | +$299,328 | $299,328 |
| VITLVITAL FARMS INC | SOLD OUT | −1.53M | 0 | −$63M | $0 |
| SMRTSMARTRENT INC | SOLD OUT | −626.9K | 0 | −$883,919 | $0 |
| OWLTOWLET INC | SOLD OUT | −35.3K | 0 | −$298,584 | $0 |
| RIVNRIVIAN AUTOMOTIVE INC | HELD | +0 | 158.36M | +$797M | $3.1B |
| ALABASTERA LABS INC | HELD | +0 | 277.8K | −$8M | $46M |
| NAUTNAUTILUS BIOTECHNOLOGY INC | HELD | +0 | 1.46M | +$2M | $3M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2025
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | RIVNRIVIAN AUTOMOTIVE INChistory → | COM CL A | 88.64% | $3.1B | 158.36M |
| 2 | BETABETA TECHNOLOGIES INChistory → | COM SHS CL A | 9.42% | $332M | 11.75M |
| 3 | ALABASTERA LABS INChistory → | COM | 1.31% | $46M | 277.8K |
| 4 | MRVLMARVELL TECHNOLOGY INChistory → | COM | 0.54% | $19M | 225.4K |
| 5 | NAUTNAUTILUS BIOTECHNOLOGY INC | COM | 0.08% | $3M | 1.46M |
| 6 | IONQIONQ INC | COM | 0.01% | $299,328 | 6.7K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $2.6B | 5 | May 5, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $3.5B | 6 | Feb 10, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $2.5B | 7 | Nov 4, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $2.4B | 9 | Aug 5, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $2.4B | 9 | May 6, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $2.7B | 9 | Feb 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $2.2B | 10 | Nov 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $2.5B | 10 | Jul 30, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $2.1B | 10 | Apr 29, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $4.1B | 9 | Jan 30, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $4.3B | 9 | Oct 18, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $3.1B | 9 | Jul 27, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | Under review | 8 | May 1, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 8 | Jan 18, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $5.6B | 9 | Oct 19, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $4.5B | 9 | Aug 2, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $8.5B | 10 | May 5, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $17.0B | 11 | Feb 2, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $490M | 7 | Oct 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $382M | 3 | Jul 28, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $60M | 2 | May 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $41M | 1 | Feb 11, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.